TCL Archive “Too much [of NCI’s] planning is reactive rather than proactive. As a consequence, vision suffers.” July 7, 1995
TCL Archive Insurer Declines To Cover Avastin For Breast Cancer, Institutes Review Procedure For Exceptional Cases October 21, 2011
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive In Brief: FASEB Letter urges Support Of NIH, NSF; Kansas Recruits Experts From Washington State July 30, 1993
